- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
American Society for Transplantation and Cellular Therapy
The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 2,600 physicians, investigators and other healthcare professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field. Learn more at astct.org.
Latest from American Society for Transplantation and Cellular Therapy
CAR-NKT cells: More of a Goldilocks or a Kangaroo?
June 22, 2022
Article
The following was recently published in ASTCT’s Nucleus publication. Follow @ATSTCT for the latest on all-things cellular therapy.
Will CAR-T Therapy Replace Transplant in Myeloma and Lymphoma?
June 20, 2022
Article
The following was recently published in ASTCT’s Nucleus publication. Follow @ATSTCT for the latest on all-things cellular therapy.
Outcomes of Patients on Transplant Waiting Lists: Q&A with Dr. Giancarlo Fatobene
June 16, 2022
Article
The following was recently published in ASTCT’s Nucleus publication. Follow @ATSTCT for the latest on all-things cellular therapy.
KIR-ligand Mismatch in CBT Outcomes Differ Based on GVHD Prophylaxes
November 22, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the use of killer immunoglobulin-like receptor–ligand mismatch and its impact on graft versus host disease.
Factors Affecting Tacrolimus Concentrations in Children with β-Thalassemia Major receiving HSCT
November 15, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the impact of genotype and voriconazole co-administration on tacrolimus trough concentration in pediatric β-thalassemia major patients following allogeneic hematopoietic stem cell transplantation.
Learn the Latest In CAR T with ASTCT Webinars
November 08, 2021
Article
Join ASTCT for a series of webinars that focus on topics relating to CAR T.
Interim Findings from the EQUATE Study Demonstrate Safety and Efficacy of Itolizumab
November 08, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the EQUATE study and its use of itolizumab.
UK Researchers Develop Simplified Manufacturing Process for CAR T Cells
November 01, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing a simplified manufacturing process for CAR T cells.
Chinese Researchers Identify Risk Factors for Poor Treatment Response to CAR T Therapy in ALL Patients
October 25, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing CAR T therapy in patients with acute lymphoblastic leukemia.
Anti-SARS-CoV-2 mRNA Vaccination After CAR T Therapy “Is Safe but Seroconversion Rate Is Low”
October 18, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the COVID-19 vaccine after CAR T therapy.
Rapamycin Pre-Treatment of CAR T Cells “May Enhance Therapeutic Efficacy Against AML”
October 04, 2021
Article
A recently published article on CAR T cells in patients with acute myeloid leukemia is featured by CancerNetwork's Strategic Alliance Partner ASTCT.
Infusion of HER2-Specific CAR T Cells into Brain or CNS “Feasible” in Pediatric Patients
September 27, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing CAR T-cell in pediatric patients with brain cancer.